†In prospective analyses, higher baseline concentrations of hs-cTnT were associated with an increased risk for dementia hospitalizations overall (hs-cTnT ≥14 ng/L compared to hs-cTnT <3 ng/L, HR 2.68, 95% CI 1.87; 3.84, p-trend<0.001). More specifically, higher troponin was associated with higher incident hospitalization for vascular dementia (P-trend = 0.029, HR not reported) but not for hospitalizations for AD (P-trend = 0.212, HR not reported). Here, TNNT2 is linked to Alzheimer disease.